W Bnouhanna

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The introduction of direct oral anticoagulants (DOA) in the early stage of cerebral infarction after thrombolysis may reduce the recurrence rate but raises safety concern. We sought to study the feasibility and safety of the introduction of rivaroxaban or dabigatran in this context. Thirty-four consecutive patients admitted for ischemic stroke related to(More)
  • 1